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Strengths and limitations of this study
 ► This study uses a two-centre randomised controlled 
trial design to determine the feasibility of a definitive 
trial.
 ► Two methods of identifying participants will be 
used: through community midwives at booking and 
through ultrasound scanning clinics.
 ► Two talking therapies will be offered to assess 
the acceptability of these interventions during 
pregnancy.
 ► A process evaluation will explore the fidelity of in-
tervention delivery and the experience of women, 
partners (or a significant other) and therapists.
 ► A definitive trial would be necessary to evaluate the 
effectiveness of the intervention.
AbStrACt
Introduction One in eight women suffer from 
depression during pregnancy. Currently, low-intensity 
brief treatment based on cognitive behavioural therapy 
(CBT) is the only talking treatment widely available in 
the National Health Service (NHS) for mild and moderate 
depression. CBT involves identifying and changing 
unhelpful negative thoughts and behaviours to improve 
mood. Mothers in our patient advisory groups requested 
greater treatment choice. Interpersonal counselling (IPC) 
is a low-intensity version of interpersonal therapy. It may 
have important advantages during pregnancy over CBT 
because it targets relationship problems, changes in role 
and previous losses (eg, miscarriage). We aim to compare 
CBT and IPC for pregnant women with depression in a 
feasibility study.
Methods and analysis A two-arm non-blinded 
randomised feasibility study of 60 women will be 
conducted in two UK localities. Women with depression 
will be identified through midwife clinics and ultrasound 
scanning appointments and randomised to receive six 
sessions of IPC or CBT. In every other way, these women 
will receive usual care. Women thought to have severe 
depression will be referred for more intensive treatment. 
After 12 weeks, we will measure women’s mood, well-
being, relationship satisfaction and use of healthcare. 
Women, their partners and staff providing treatments will 
be interviewed to understand whether IPC is an acceptable 
approach and whether changes should be introduced 
before applying to run a larger trial.
Several groups of patients with depression during 
pregnancy have contributed to our study design. A 
patient advisory group will meet and advise us during 
the study.
Ethics and dissemination Study results will inform 
the design of a larger multicentre randomised controlled 
trial (RCT). Our findings will be shared through public 
engagement events, papers and reports to organisations 
within the NHS. National Research Ethics Service 
Committee approved the study protocol.
trial registration number ISRCTN11513120.
IntroduCtIon
Antenatal depression is common, with a 
reported prevalence of 11%1 and a point 
prevalence of up to 44% in certain popula-
tions.2 Antenatal depression is associated 
with a range of poor outcomes including 
continuing depression into the postnatal 
period, reduced breastfeeding rates,3 infant 
developmental delay4 and social/emotional 
problems, including depression in the 
offspring during adolescence.5 Pregnancy 
does not appear to be protective against 
developing depression or relapsing in those 
with a previous history of depression.6
Currently, the Whooley questions are used 
to identify women who may have antenatal 
depression.7 This screening method has 
high sensitivity (95%) and modest specificity 
(65%) for antenatal depression.8 However, 
anecdotal evidence suggests that women are 
not always aware that they are referred for 
further help following a positive Whooley 
screen.9
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There is limited evidence for the effectiveness of psycho-
logical interventions for antenatal depression,10 despite a 
widespread reluctance of mothers to take antidepressants 
during pregnancy11 with 75% of women discontinuing anti-
depressant medication in the first trimester.12 There is also 
concern among clinicians about prescribing antidepressant 
medication,13 largely due to a lack of evidence regarding 
their safety,14 indicating that psychological interventions 
are particularly important at this time.10 15 One study found 
that women who discontinue antidepressant medication 
during pregnancy are five times more likely to experience 
a relapse in their depression requiring treatment.6 The 
current treatment recommendation for mild to moderate 
depression, including depression that occurs during preg-
nancy, is a brief, one-to-one supported self-help approach 
using the principles of cognitive behavioural therapy (CBT) 
known as low-intensity CBT.
theoretical basis of Cbt and limitations for this population
The theoretical basis of CBT is that individuals prone to 
depression hold dysfunctional beliefs and therefore see the 
world through a negative filter.16 Adversity, such as preg-
nancy, triggers these underlying beliefs and prone indi-
viduals then behave in a way that is consistent with these 
negative beliefs thus triggering and reinforcing depression. 
There is no specific relevance of this model to pregnancy 
and it relies on the skill of the therapist to adapt CBT to indi-
vidual circumstances. Although there is a growing evidence 
base for ‘high intensity’ CBT delivered by experienced 
therapists for perinatal depression, ‘low-intensity’ CBT is 
briefer and delivered by less experienced practitioners who 
have limited scope to adapt to the perinatal context and be 
flexible in its use. The use of high-intensity CBT is limited 
within current clinical frameworks due to limitations in 
funding and therapist availability. CBT has few explicit strat-
egies to manage many of the problems that are common 
for women with antenatal depression, including role transi-
tions and problems in relationships.
A recent review highlighted the need for more person-
alised therapies to treat perinatal depression, including inter-
personal psychotherapy as a plausible treatment option.17 
Women in our patient advisory group consultations reported 
that CBT is ‘too clinical’ and ‘inflexible’ with practitioners 
not appearing to consider the circumstances of pregnancy. 
This may be one reason why the uptake of CBT treatment for 
antenatal depression is low. It has been reported that 14% of 
women with antenatal depression receive psychological treat-
ment and only 5% with antenatal depression achieve remis-
sion following treatment.18 Women who are pregnant receive 
lower rates of psychological intervention than those outside 
the perinatal period (30% vs 50%) despite an increased need 
for psychological treatment rather than drug treatment at 
this time.
theoretical basis of interpersonal counselling and advantages 
for treating antenatal depression
Interpersonal counselling (IPC) is a brief treatment 
which may be more appropriate for addressing the prob-
lems that depressed women have during pregnancy and 
postnatally. It is derived from interpersonal therapy, 
which holds that interpersonal relationships are a basic 
human need and attachment to key individuals provides 
a secure base from which to manage stressful events and 
conditions.19 Problems in interpersonal relationships 
can trigger symptoms of depression, such as low mood 
or sleeplessness, and these symptoms further compro-
mise relationships leading to a downward spiral.20 This 
is particularly relevant to pregnancy as conflict in rela-
tionships and poor social support are the strongest risk 
factors for antenatal depression.21
IPC offers a more structured version of IPT that 
promotes understanding of depression through psycho-
education, problem solving and active involvement of 
the people in the person’s life to provide support and 
promote recovery. IPC helps individuals develop useful 
strategies to manage interpersonal conflict and can 
involve the partner if appropriate. It also focuses on 
approaches that help manage changes in role, conflict, 
isolation and loss (ie, miscarriage, stillbirth, termination, 
previous loss of would be grandparents) and the impact 
of these on relationships. By directly approaching these 
issues, IPC addresses what is theoretically central to 
depression and what service users report are significant 
worries and concerns for them. The approach is simple 
and focused and could be provided by practitioners who 
have limited training or experience.
Currently, there are limited data on the effectiveness of 
IPC.14 It is critical to test its effectiveness because although 
almost half (43%, n=2 01 591 in 2015–16) of all indi-
viduals who receive a talking treatment in the National 
Health Service (NHS) will receive a brief, ‘low-intensity’ 
treatment, interpersonal brief treatment approaches are 
currently not available in the NHS.22
IPC has been clearly developed and rigorously manual-
ised as an intervention allowing assessment of fidelity to 
the model. Although there have been very few studies of 
the effectiveness of IPC, and none in the UK, one study 
of depression in primary care in Italy found IPC to be 
more effective than antidepressants Selective serotonin 
reuptake inhibitor (SSRIs) particularly for those with less 
severe depression,23 and a small UK pilot study found that 
IPC is an effective and acceptable treatment for young 
people with primarily depressive symptoms.24 A small 
feasibility study of IPC for antenatal depression in the 
USA among low-income mothers indicated high satisfac-
tion with IPC and some improvement in mood.25
There are therefore good reasons to hypothesise that 
IPC may be more acceptable at this time and particularly 
effective in treating antenatal depression. There is some 
evidence that interpersonal therapy (IPT), a high-inten-
sity therapy from which IPC is derived is more acceptable 
than 'high intensity' CBT, with sessions more likely to 
be attended and that outcomes are better for IPT than 
'high intensity' CBT in existing psychological treatment 
services.22 We argue that evaluating this intervention for 
treating antenatal depression is particularly important 
because:
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box 1: detailed study objectives
To determine whether a full trial is feasible by assessing:
1. Whether staff who currently deliver low-intensity interventions 
within routine psychological treatment services, known nationally 
as Improving Access to Psychological Treatment (IAPT) services, 
can reliably deliver this newly adapted therapy after brief, additional 
training.
2. Whether it is possible to recruit women from community midwife 
booking clinics and through screening at the ultrasound scanning 
clinics.
3. Whether it is feasible and acceptable to randomise women following 
assessment.
4. How acceptable IPC is to women, partners and those delivering the 
intervention relative to low-intensity CBT, assessed through qualita-
tive interviews.
5. Whether it is possible to collect sufficient outcome data, including 
those required to perform an economic evaluation.
1. The model is particularly relevant to pregnanc,y and 
therefore the advantages of this approach over stan-
dard CBT treatment may be greater than at other 
times.26
2. Psychological treatment provision is a priority at this 
time because of the potential risks of antidepressants 
during pregnancy and the costs of depression during 
pregnancy.27
Training low-intensity practitioners in IPC has the 
potential to offer women an acceptable, empirically valid 
option which may prove to be more effective than CBT 
and provide the NHS with a treatment option that may be 
both effective and cost-effective.
Aims and objectives
Our overall aim is to improve psychological treatment 
for depression during pregnancy to improve outcomes 
for the mother, infant and the wider family. We aim to 
test whether six sessions of IPC are acceptable, effective 
and cost-effective for treating mild to moderate antenatal 
depression compared with the most commonly provided 
existing intervention, low-intensity CBT. Both inter-
ventions are one-to-one therapies comprising up to six 
sessions.
The aim of this first study is to establish the feasibility 
and acceptability of conducting a full-scale randomised 
controlled trial (RCT) to compare the effectiveness of 
these two low-intensity interventions for antenatal depres-
sion. Using a pragmatic study design operating within the 
existing care pathway, we will explore whether a full-scale 
trial using such a design is feasible. Study objectives are 
shown in Box 1.
MEthodS And AnAlySIS
Study design
This feasibility study over 21 months will be carried out in 
two centres (site A and site B) in preparation for a prag-
matic fully powered RCT. Women with mild to moderate 
depression during pregnancy considered suitable for a 
low-intensity intervention will be randomised 1:1 either 
to the usual low-intensity treatment (CBT) or to a novel 
treatment called IPC.
Study population, setting and recruitment plan
Women who are aged 18 years or over are eligible for 
inclusion between 10 and 24 weeks of pregnancy, with an 
Edinburgh Depression Scale (EPDS) score of 10 or above 
and mild or moderate depression according to Clinical 
Interview Schedule Revised (CIS-R),28 which gives an 
International Classification of Diseases 10th Revision 
diagnosis, whether or not they are taking an antidepres-
sant. Both primiparous and multiparous women will be 
eligible. Recruitment will continue for 9 months.
We will exclude women with psychotic illness, organic 
brain disorder, bipolar disorder, personality disorder, 
alcohol or substance dependency, which will be identified 
through self-report. Also excluded will be those judged 
to be at high suicide risk in assessor’s judgement or from 
response to items on suicide in CIS-R or EPDS, those with 
severe depression according to CIS-R criteria and those 
who have had CBT or IPT within the last 6 months. If 
women miscarry or have a termination during the trial, 
they will be offered the opportunity to continue with the 
treatment but will not be included in the rest of the study.
We will compare recruitment through two routes which 
have been used successfully in two previous trials of ante-
natal depression and antenatal anxiety.29 30
Method 1: Women will be identified at community 
midwife booking clinics (around 8–10 weeks’ gestation) 
through the routine screening undertaken for depression 
using the Whooley questions.8 Those who answer ‘yes’ to 
either question and are considered by the midwife to be 
appropriate for further assessment for talking therapy, 
will be asked for their consent to be contacted by the 
research team about the study.
Method 2: Women will also be identified from ultra-
sound scan clinics where they will be given study informa-
tion, eligibility screening questions (EPDS) and a form to 
indicate their willingness to be contacted by the research 
team for assessment if screening positive (EPDS 10 or 
above). This approach will provide a good opportunity to 
recruit disadvantaged groups, as attendance at scanning 
clinics does not appear to be socially patterned.31
Where needed, interpreters will be used to ensure that 
those who do not have English as a first language can be 
offered therapy.
Figure 1 shows the flow of participants through the trial.
Assessment and randomisation
A researcher will conduct a telephone assessment with 
women who consent to be contacted. At a subsequent 
face-to-face meeting, the researcher will establish eligi-
bility for the trial, obtain written consent and collect 
baseline data. Partners will also be asked for their consent 
either in person at the baseline visit, online or by post.
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Figure 1 ADAGIO study flow diagram. CBT, 
cognitivebehavioural therapy; CIS-R, Clinical Interview 
Schedule Revised; EPDS, Edinburgh Depression Scale; 
IAPT, Improving Access to Psychological Therapies; IPC, 
interpersonal counselling.
Randomisation will be carried out remotely by Bristol 
Randomised Trials Collaboration randomisation service. 
It will be stratified by recruiting centre and minimised by 
parity (with random block sizes).
treatment arms
We have embedded the treatments within existing 
psychological treatment services available in primary care 
(Improving Access to Psychological Therapies (IAPT)). 
For women with mild or moderate depression during 
pregnancy considered suitable for a low-intensity inter-
vention, we will compare up to six sessions of either 
low-intensity CBT or IPC.
training and supervision for practitioners
To avoid potential selection bias, 12 psychological well-
being practitioners will be randomised, 6 to be trained in 
IPC and 6 to continue delivering low-intensity CBT.
IAPT low-intensity (brief therapy) practitioners who 
agreed to take part in the study and are randomised to the 
IPC group will receive 3 days of training from RL (coap-
plicant; chair of IPT UK; experienced, certified IPT/IPC 
trainer). Supervisors for the practitioners, who are already 
trained in IPT (the model from which IPC is derived) 
will attend the training days. The practitioners will be 
required to audiorecord cases, which will be assessed by 
their supervisor to ensure competence and fidelity to the 
model. Supervision will be provided weekly initially and 
then fortnightly once practitioners are more familiar with 
IPC. Those delivering the six sessions of CBT will be given 
refresher training and have fortnightly case supervision as 
is usual practice for CBT. Supervisors will rate adherence 
from a checklist and feedback to trainees. These ratings 
will be used to assess fidelity.
data collection and management
All data collected and analysed during the study will be 
pseudoanonymised using a unique identifier. A record of 
trial participants’ names and contact details and assigned 
trial numbers will be maintained by the trial coordinator 
and stored separately and securely for administrative 
purposes. Study data collected by the research team will be 
recorded on study-specific data collection forms (CRFs). 
Data will then be entered onto a REDCap database.
baseline measurements
Baseline data will be collected at an initial face-to-face 
assessment with women and will include measures of 
mood, quality of life, quality of relationship with partner 
and antenatal attachment. Partners will also be invited to 
complete a depression rating scale.
Follow-up measurements
Assessments will be completed either online by partici-
pants or over the telephone with a researcher 12 weeks 
following randomisation. This allows time for women 
to be allocated to therapy and to complete the sessions. 
Non-responders will receive two automatic online or tele-
phone reminders 1 week apart, with attempts to collect 
data by telephone a week later if necessary.
Measures at baseline and 12 weeks
1. CIS-R a computerised structured psychiatric interview 
(at baseline only).
2. EPDS32 continuous and binary scores from women and 
their partners. The scale, sometimes known as the Ed-
inburgh Depression Scale, was developed for postnatal 
depression but is widely used during pregnancy and 
has been validated outside the postnatal period and 
for men.33 34
3. The Revised Dyadic Adjustment Scale35 assesses part-
ner satisfaction.
4. Maternal Antenatal Attachment Scale.36
5. Health economic measures outlined below (EQ-5D-
5L, ReQol10).
6. At 12 weeks only: the number of sessions attended, 
number that include the partner, whether step up to 
more intense psychological intervention is needed, 
use of medication and use of secondary mental health 
services.
blinding
It will not be possible for assessors or participants to be 
blind to allocation; however, the statistician will be blind 
to allocation of participants.
outcomes
The primary outcome will be the proportion of 
eligible women successfully recruited to the point of 
randomisation.
We will assess numbers and proportions of participants:
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 ► Recruited for assessment (comparing two methods of 
recruitment).
 ► Randomised.
 ► Completing the course of treatment.
 ► Completing follow-up measures.
 ► Requiring ‘step up’ to a higher intensity intervention.
We will assess the acceptability of the recruitment 
method, intervention and study design through a 
series of in-depth interviews with participants and IAPT 
practitioners.
The primary outcome for a future trial is likely to be 
changed in EPDS score, but we will also consider the 
other secondary outcomes collected in this trial.
Sample size determination
As this is a feasibility study, the sample size should be 
sufficient to measure feasibility parameters and data 
completeness with adequate precision.
There are around 3000 pregnancies per year at site A 
and 1500 at site B (total 4500) in the relevant IAPT catch-
ment areas, giving a total of approximately 3375 pregnan-
cies in the 9-month recruitment period. Assuming 10% 
of these have mild–moderate antenatal depression (338) 
and recruiting through both midwives booking appoint-
ments and ultrasound scanning clinics, we aim to include 
60 women. This target of 60 subjects from 338 potentially 
eligible women (17.8%) gives a 95% CI for recruitment 
between 13.9% and 22.3%.
Economic evaluation
A full economic evaluation is not possible based on 
the results of this feasibility study. Within the feasibility 
study, we assess whether and how necessary data can be 
collected. We will pilot methods for collecting resource 
use data in this population and use the results to plan the 
future main trial. Intervention delivery resource will be 
recorded.
The main economic outcome measure collected will 
be the EQ-5D-5L, a generic preference-based measure 
of health.37 Recognising that non-health dimensions 
of well-being were important to our Patient and Public 
Involvement (PPI) group, we will also collect data on the 
ReQoL10 instrument, an alternative preference-based 
outcome tool that includes domains beyond health and 
has been developed specifically for use in groups with 
mental health problems ( www. requol. org. uk). Resource 
use data will be collected online or by telephone as part of 
the 12-week follow-up. We will ask participants to report 
resource use during the time enrolled on the study.
Qualitative study
We will collect qualitative data through interviews to assist 
in determining the feasibility and acceptability of the 
intervention and trial design. We will explore the accept-
ability of the intervention to women receiving IPC and 
CBT; the feasibility of recruitment and follow-up.
We will conduct semistructured interviews either face 
to face or on the phone. It is anticipated interviews will 
last between 30 min and 1 hour. Topic guides will be 
informed by the research literature, team discussions and 
input from PPI. We will interview the following groups:
i) Women in the treatment arms
These will be conducted at the completion of either 
IPC (10–12 women) or CBT (5–6 women). Purposive 
maximum variation sampling will ensure that women from 
different age groups, socioeconomic status, ethnicity and 
different levels of engagement with the intervention are 
selected from both study sites. Interviews will focus on the 
acceptability and perceived effectiveness of the talking 
therapy and explore views on the recruitment process; 
helpful and challenging aspects of the intervention and 
the appropriateness of the outcome measures being used.
ii) Partners (or significant others) of those receiving IPC or CBT
Interviews will be conducted with five or six partners 
focusing on the acceptability and perceived effectiveness 
of the intervention and explore ways they feel their part-
ners have benefited from the talking therapy.
iii) Participants who drop out
We will seek the views of participants who withdrew or 
did not attend the intervention to understand their 
reasons for dropping out and whether continuing partic-
ipation (and engagement in the intervention) could be 
supported. These will be short telephone interviews and 
we would attempt to contact them up to three times.
iv) Staff
Interviews (six to eight) with practitioners in the IPC arm, 
their supervisors and community midwives, will be carried 
out at the end of the intervention and focus on the accept-
ability, strengths and weaknesses of the intervention.
data analyses
Quantitative data analysis
As this is a feasibility trial, no formal statistical testing will 
be carried out. Instead, the analysis will focus on reporting 
data that will be used for planning and for assessing the 
feasibility of the full trial.
A Consolidated Standards of Reporting Trials flow 
diagram will be produced. Proportions with 95% CIs 
calculated using the Exact Binomial Method will be 
produced for:
 ► Participants consented.
 ► Participants who are randomised with completed 
baseline measures.
 ► Participants randomised to IPC who complete it.
 ► Participants randomised to low-intensity CBT who 
complete it.
 ► Randomised participants lost to follow-up.
 ► Randomised participants who require ‘step up’ to a 
higher intensity intervention.
 ► Randomised participants who have complete outcome 
data.
Baseline characteristics and demographic charac-
teristics will be tabulated by treatment group (defined 
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by intention to treat) and overall. Means or medians 
together with appropriate measures of dispersion will be 
reported for continuous measures and proportions for 
binary measures. The follow-up outcome data (namely 
the EPDS, Revised Dyadic Adjustment Scale, Maternal 
Antenatal Attachment Scale, number of sessions attended, 
number of sessions partner attended, medication use 
and secondary health service use) will be reported in the 
same way. Plots will be used to examine the distribution of 
continuous outcomes.
Qualitative data analysis
All interviews will be audiorecorded, transcribed verbatim 
and anonymised. Thematic analysis methods38 will be 
used with NVivo to aid data management. Interview tran-
scripts will be read and reread individually, from which 
an initial coding framework will be developed. Team 
members will meet to discuss the preliminary coding 
framework and themes to ensure that the emerging anal-
ysis is trustworthy and credible. This framework will be 
added to and refined, with coded material regrouped as 
new data from subsequent interviews are gathered.
Patient and public involvement/patient advisory group
Discussions with women who have perinatal mental health 
problems and are currently using services, colleagues 
running voluntary sector perinatal mental health services 
and feedback from public engagement events have all 
highlighted the need to improve psychological treatment 
services available to women and their partners during 
pregnancy and following childbirth. We asked women 
attending an antenatal group for those with mental 
health problems in pregnancy what they thought would 
have helped them most, and they highlighted the need 
for a therapy that is more specific to pregnant women. 
Some reported that current treatment offered (CBT) was 
‘too clinical’, and those providing the treatment made 
little reference to pregnancy or worries about coping 
with a young baby. We have two collaborators who run 
voluntary sector organisations providing help to women 
with mental health problems during the perinatal period. 
One has been involved in the development of the ideas 
surrounding this, and the other has been providing 
advice about women’s experience of local psychological 
treatment services as well as commenting on the proposal 
and several aspects of the design. At two public engage-
ment events held in Bristol, we discussed services for 
families and how these could be improved. At one event 
for fathers whose partners struggled with their mood and 
anxiety during pregnancy or following childbirth, they 
gave a clear message that they felt excluded and even 
treated with suspicion by services. Fathers welcomed any 
psychological treatment which might include them and 
focus on improving the relationship with their partner. 
Six women, who have been attending either an antenatal 
group aimed at promoting emotional well-being or post-
natal drop-in sessions run by the voluntary sector, have 
agreed to form a patient advisory group (PAG) meeting 
three times during the study.
The PAG members will assist in the development of 
patient facing materials, advise on recruitment issues, 
inform the development of the topic guide for the quali-
tative interviews and discuss and help interpret the results 
including the decision on whether to proceed to a full 
trial. They will be offered a study-specific induction pack 
which will include the INVOLVE materials and relevant 
study information. Training workshops run by People and 
Research West of England will also be offered to them. 
PAG members will have their travel expenses and meeting 
time reimbursed with vouchers. Our findings will be 
presented in lay terms at a PAG meeting, and they will 
advise us on routes for dissemination to patient groups.
Ethics, monitoring and dissemination
This manuscript is based on Protocol V.3.0 dated 
14/06/2019. The study received North of Scotland 
Research Ethics Committee (REC) approval on 29 
October 2018 and Health Research Authority approval on 
14 November 2018. The trial will be conducted in accor-
dance with the protocol, the principles of the Declaration 
of Helsinki and International Conference on Harmoni-
sation of technical requirements for registration of phar-
maceuticals for human use Good Clinical Practice (ICH 
GCP). Any amendments of the protocol will be submitted 
to the REC for approval. On request, the study investiga-
tors and their institutions will permit trial-related moni-
toring and audits by the sponsor and relevant research 
ethics committee by providing direct access to source 
data and other documents (ie, patients’ hospital notes). 
The University of Bristol holds the relevant insurance for 
this study and is the nominated sponsor for this study.
A trial steering committee (TSC) has been convened 
to provide overall supervision of the trial and ensure it is 
in accordance with the principles of good clinical prac-
tice and relevant regulations. The TSC agreed the trial 
protocol and will agree any protocol amendments. The 
TSC also provides advice to the investigators on all aspects 
of the trial including aspects of safety and monitoring of 
serious adverse events. The TSC is chaired by Professor 
Paul Ramchandani with three independent members 
who have expertise in clinical psychology and perinatal 
mental health, midwifery for NHS England and statistics.
dissemination
A lay summary of the study is available on the National 
Institute for Health Research website. Results of this feasi-
bility study will be publicly available through open access 
publication in a peer-reviewed journals and presented 
at relevant conferences and research meetings. The PPI 
groups will contribute to the dissemination plan and 
assist in the production of the lay summaries.
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